Alk-positive Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Alk-positive Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-09-24FDA Approved: ALUNBRIG — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ALUNBRIG (brigatinib) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2013-09-13FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for XALKORI (crizotinib) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2013-02-28FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XALKORI (crizotinib) from Pfizer Laboratories Div Pfizer Inc.